文献速递神经免疫脑血管病

疑似特发性横贯性脊髓炎患者中多数可明确特异性脊髓病诊断

Evaluation of idiopathic transverse myelitis revealing specific myelopathy diagnoses.
PubMed 文献 · Neurology · 2017-12-15

该研究回顾性分析了2010至2015年转诊至Mayo Clinic神经科、疑似特发性横贯性脊髓炎(ITM)的226例18岁以上患者,应用现行ITM诊断标准及替代脊髓病诊断标准重新评估。结果显示仅18.1%符合ITM诊断,69.9%明确了替代特异性脊髓病诊断,24%因最终诊断而需要调整治疗。

要点

  • 疑似ITM患者中仅18.1%符合ITM诊断标准,69.9%有替代特异性脊髓病诊断。
  • 最常见的替代诊断为多发性硬化或临床孤立综合征(75例)和血管性脊髓病(41例)。
  • 24%的患者因最终诊断而需要调整治疗,提示推定ITM诊断可能影响治疗决策。

核心结论

  • 大多数疑似ITM患者存在替代的特异性脊髓病诊断。
  • 推定ITM诊断可能导致过早的診斷结论并影响患者治疗。

研究设计与样本

  • 回顾性研究,纳入2010年12月1日至2015年12月31日转诊至Mayo Clinic神经科的226例18岁及以上疑似ITM患者。
  • 通过电子病历回顾临床表现、病程、实验室和电生理检查及神经影像学以确定病因,并应用现行ITM诊断标准和替代脊髓病诊断标准。
  • 对所有疑似与最终报告临床诊断不符的病例,由每位作者审核并达成共识最终诊断。

主要发现

  • 226例中41例(18.1%)符合ITM诊断标准。
  • 158例(69.9%)明确了替代特异性脊髓病诊断:多发性硬化或临床孤立综合征75例,血管性脊髓病41例,神经结节病12例,视神经脊髓炎谱系疾病12例,髓鞘少突胶质细胞糖蛋白脊髓病5例,肿瘤性4例,压迫性3例,营养性3例,感染性2例,其他2例。
  • 27例未确认脊髓病。
  • 无ITM的患者从症状发作到最终临床诊断的中位时间为9个月(范围0-288)。

临床怎么用

  • 对疑似ITM患者应系统评估以排除替代特异性脊髓病诊断,避免过早推定ITM诊断。
  • 最终诊断可能改变治疗决策,需在诊断明确后重新评估治疗方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate specific myelopathy diagnoses made in patients with suspected idiopathic transverse myelitis (ITM). METHODS: A total of 226 patients 18 years and older were referred to Mayo Clinic Neurology for suspected ITM from December 1, 2010, to December 31, 2015. Electronic medical records were reviewed for detailed clinical presentation and course, laboratory and electrophysiologic investigations, and neuroimaging to determine the etiology. Current diagnostic criteria for ITM and alternative myelopathy diagnoses were applied. All cases where any discrepancy was suspected from the final reported clinical diagnosis were reviewed by each author and a consensus final diagnosis was made. RESULTS: The diagnostic criteria for ITM were met in 41 of 226 patients (18.1%). In 158 patients (69.9%), an alternative specific myelopathy diagnosis was made: multiple sclerosis or clinically isolated syndrome, 75; vascular myelopathy, 41; neurosarcoidosis, 12; neuromyelitis optica spectrum disorder, 12; myelin oligodendrocyte glycoprotein myelopathy, 5; neoplastic, 4; compressive, 3; nutritional, 3; infectious, 2; and other, 2. A myelopathy was not confirmed in 27 patients. Time from symptom onset to final clinical diagnosis in patients without ITM was a median of 9 months (range 0-288). Fifty-five patients (24%) required treatment changes according to their final clinical diagnosis. CONCLUSIONS: The majority of patients with suspected ITM have an alternative specific myelopathy diagnosis. A presumptive diagnosis of ITM can lead to premature diagnostic conclusions affecting patient treatment.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Zalewski NL, Flanagan EP, Keegan BM, et al. Evaluation of idiopathic transverse myelitis revealing specific myelopathy diagnoses. Neurology. 2017. PMID: 29247071. doi:10.1212/WNL.0000000000004796

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。